Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
38.01
-0.01 (-0.03%)
Streaming Delayed Price
Updated: 1:36 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,293,728
Open
38.39
Bid (Size)
38.01 (300)
Ask (Size)
38.02 (1,900)
Prev. Close
38.02
Today's Range
37.70 - 38.80
52wk Range
35.85 - 82.57
Shares Outstanding
N/A
Dividend Yield
3.07%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Real Reason Eli Lilly Is Pouring $3 Billion Into China
↗
Today 12:22 EDT
Via
MarketBeat
The Great Pivot: How the Novo Nordisk Deal Transformed Hims & Hers (HIMS) into a Healthcare Powerhouse
Today 9:38 EDT
As of March 13, 2026, the healthcare landscape has witnessed one of the most significant pivots in the history of digital health. Hims & Hers Health, Inc. (NYSE: HIMS) has officially transitioned from...
Via
Finterra
Topics
Economy
Performance
YTD
-27.4%
-27.4%
1 Month
-22.6%
-22.6%
3 Month
-24.4%
-24.4%
6 Month
-30.0%
-30.0%
1 Year
-49.2%
-49.2%
More News
Read More
Does This Deal Make Novo Nordisk Stock a Buy?
↗
March 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Lawsuit
The New Era of Hims & Hers Health (HIMS): Navigating the Branded Obesity Drug Pivot
March 12, 2026
Via
Finterra
Forget Oral Wegovy: This Weight Loss Drug Could Be an Even Bigger Winner
↗
March 11, 2026
Via
The Motley Fool
Hims & Hers Stock Skyrockets as Landmark Settlement with Novo Nordisk Ends Weight-Loss Drug War
March 11, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Lawsuit
The Greenland Ultimatum: Trump Weaponizes Tariffs in Bid for the Arctic's 'Crown Jewel'
March 11, 2026
Via
MarketMinute
Topics
Economy
Electric Vehicles
Government
The Dow’s Anchor: How UnitedHealth’s ‘Great Reset’ is Dragging Down the Blue-Chip Average
March 11, 2026
Via
MarketMinute
Topics
Stocks
Hims & Hers Health Stock Is Surging Wednesday: What's Going On?
↗
March 11, 2026
Via
Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
March 10, 2026
From
Pomerantz LLP
Via
GlobeNewswire
The Great Biotech Divide: Vertex Soars on Multi-Franchise Breakthroughs as Novo Nordisk Stumbles in the Weight-Loss War
March 10, 2026
Via
MarketMinute
Novo Nordisk Sentiment Shifts as REDEFINE 4 Trial Results Trigger 16% Stock Plunge
March 10, 2026
Via
MarketMinute
Topics
Government
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal
↗
March 10, 2026
Via
MarketBeat
Viking CEO Sees Its Obesity Drug Beating Novo's Wegovy In Weight Loss
↗
March 10, 2026
Via
Stocktwits
2 Healthcare Stocks That Are Too Cheap to Ignore
↗
March 10, 2026
Via
The Motley Fool
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
March 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Lawsuit
Disrupting the Pharmacy: A Deep-Dive into Hims & Hers Health (HIMS) in 2026
March 10, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock
↗
March 10, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock Rockets To Best Day Ever After Novo Nordisk Pact — Wall Street Upgrades Roll In As Shorts Lose $546M In One Day
↗
March 10, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
↗
March 09, 2026
Via
The Motley Fool
Topics
Lawsuit
Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock
↗
March 09, 2026
Via
The Motley Fool
Hims & Hers Stock Pops 40%: Everything You Need to Know
↗
March 09, 2026
Via
The Motley Fool
Topics
Lawsuit
HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy
↗
March 09, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
HIMS Stock Could Rally Up To 60% This Week? Fund Manager Says He Wouldn’t Be ‘Surprised’ As Novo Nordisk Patch-Up Buzz Grows
↗
March 09, 2026
Via
Stocktwits
Topics
Intellectual Property
Lawsuit
Better Weight Loss Stock: Novo Nordisk Vs. Amgen
↗
March 08, 2026
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 38.01
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 03/13/26 01:36 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.